ژنتیک رتینوپاتی دیابتی: بررسی نقش ژن VEGF
Authors
Abstract:
Background: VEGF is newly discovered growth factor that has diverse biologic properties. The bottom-line of these activities is conduction and orchestration of a series of reactions that are taking place at microvasculature of different tissues/organs. Among the growth factors, cytokines and other mediators that reflect meaningful alteration in their local/systemic level, VEGF is the distinct player which can explain by its own all hemodynamic and architectural manifestations present in diabetic retinopathy (DR). The present study was conducted to pursue the role of a candidate gene structure variation, VEGF gene polymorphisms, in genetic susceptibility/resistance to development of DR through a cross sectional case-control study. Methods: The frequency of four SNPs in VEGF gene at positions –7*C/T, –1001*G/C, –1154*G/A and –2578*C/A has been traced among 248 type 1 diabetic subjects (135 DR+, 113 DR−) along with 95 healthy controls. The populations had "British-Caucasian" background and ARMS-PCR technique was employed for DNA genotyping.Results: Comparing the polymorphic variants' frequency at both allelic and genotypic levels among different groups/subgroups, significant difference was noticeable for –7*C/T polymorphism between diabetic patients with vs. without DR, while T allele conferred protective effect (p=0.002 OR=1.98). Conclusion: Contemplating that up-regulation/over-expression of VEGF (local/systemic) as a common pre-requisite for DR development, our hypothesis was that whether the VEGF gene structural variations is correlated with the magnitude of VEGF expression in response to different stimuli present in diabetic context, namely hypoxia and hyperglycemia. Our data indicate that among the examined polymorphisms of VEGF gene, only SNP at position –7*C/T harbored significant difference between DR+ vs. DR− cases, proposing phenotypic impact for that SNP illustrating by evolvement/impediment of DR. However, reminding the insubstantial role of genetic issues in development of DR relative to DN or DNU, replicating current hypothesis by providing larger sample size and also employing more polymorphic markers could shed more light on the subject of present study.
similar resources
ژنتیک نوروپاتی دیابتی: بررسی نقش ژن VEGF
Background: Vascular factors in conjunction with metabolic issues are involved in both etiopathogenesis of diabetic neuropathy (DNU), and more remarkably in "repair" phase, when the net balance between neuroregenerative/degenerative reactions is dictated to some extent by these factors. The ischemic nature of DNU indicates the importance of re-establishment of blood vessels. VEGF, a growth fact...
full textبررسی ارتباط بین پلی مورفیسم ژن vegf و رتینوپاتی دیابتی در بیماران دیابتی نوع 2
چکیده فارسی : رتینوپاتی دیابتی یکی از عوارض شایع میکروواسکولار در بیماران دیابتی است که یکی از عوامل مهم نابینایی در جهان محسوب می شود. vascular endothelial growth factorبه عنوان یک فاکتور آنژیوژنز قوی و هم چنین فاکتور نفوذپذیری عروق نقش مهمی را در ایجاد عوارض دیابت ایفا می کند. در تحقیق حاضر dna جدا شده از 200 بیمار دارای دیابت انجام شد که 101 نفر از آن ها دارای رتینوپاتی دیابتی (dr) و 99...
15 صفحه اولژنتیک نفروپاتی دیابتی: بررسی نقش ژن TGF-1
Background: Despite substantial progress in the clinical management of diabetes, diabetic nephropathy (DN) still occurs recurrently, implicating diabetes as the major underlying condition leading to the end stage renal disease. One of the main reasons is the influential role of genetic or inherited backgrounds of diabetics that are almost overlooked in daily practice. Owing to be orchestrated b...
full textمطالعه ژن کاندیدا در رتینوپاتی دیابتی: ژن eNOS
Background: Due to homeostatic and regulatory potentials of nitric oxide (NO) in vascular physiology, regulatory systems that determine NO bio-synthesis and bioavailability have been the subject of extensive research in molecular medicine. In the field of vascular system pathophysiology, endothelial nitric oxide synthase (eNOS) which is the major producer and regulator of NO in vascular tissues...
full textمطالعه ژن کاندیدا در رتینوپاتی دیابتی: ژن I-IGF
Background: The alteration of IGF-I systemic level in diabetes is typically characterized by depletion of free IGF-I plasma level and its decreased bioavailability. With regard to protective and advantageous effects of IGF-I on tissue healing and cellular regeneration such depletion could facilitate or accelerate tissue damages and complications. By contrast, the local concentration of IGF-I i...
full textآنالیز ژن های mnsod و vegf در بیماران مبتلا به رتینوپاتی دیابتی
رتینوپاتی دیابتی (dr) وخیم ترین عارضه ی میکرووسکولر چشمی در دیابت بوده و علت عمده ی نابینایی در جمعیت سنین کار در کشورهای پیشرفته محسوب می شود. استرس اکسیداتیو نقش مهمی را در ایجاد عوارض میکرووسکولر مانند افزایش نفوذپذیری مویرگی و تشکیل مویرگ های جدید به عهده دارد. آنزیم سوپراکسید دسموتاز میتوکندریایی ((mnsod یک آنزیم آنتی اکسیدان کلیدی در مکانیسم دفاع سلولی در برابر عوامل ایجادکننده ی استرس اک...
15 صفحه اولMy Resources
Journal title
volume 5 issue None
pages 197- 206
publication date 2006-05
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023